Additional Guidelines (1)
{"Image DocumentName": "Additional Guidelines (1)", "Image ImageDescription": "EMA Guidelines. Start of shelf-life of the finished dosage form (Annex to NFG on the manufacture of the finished dosage form): CPMP/QWP/072/96 (December 2001) EU Commissions Guidelines. Notice to applicants: Dossier requirements for Type 1A and type 1B notifications \u2013 Volume 2C (June 2006) US FDA CDER 21 CFR Part Current Good Manufacturing Practice for Finished Pharmaceuticals-Stability Testing. US FDA CDER Guidance for Industry. Changes to an Approved NDA or ANDA April 2004.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}